This statistic shows the distribution of health insurance expenditure for treatments with antidepressants or mood stabilizers (excluding pathologies) in France in 2017, by type. That year, the cost of ambulatory care treatments amounted to more than 1.2 billion euros.
Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2017, by type
(in million euros)
The source adds the following information: "Treatment Definition Algorithm: Persons who have received at least three ATC (Anatomic, Therapeutic and Chemical Class) N06A (except levotonin) antidepressant deliveries, lithium, Depakote or Depamide during the year n (at different dates), and who have no new psychiatric pathology."
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Cnamts. (September 30, 2019). Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2017, by type (in million euros) [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/756355/health-insurance-antidepressant-spending-france/
Cnamts. "Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2017, by type (in million euros)." Chart. September 30, 2019. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/756355/health-insurance-antidepressant-spending-france/
Cnamts. (2019). Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2017, by type (in million euros). Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/756355/health-insurance-antidepressant-spending-france/
Cnamts. "Antidepressant and Mood-stabilizing Treatment Expenses (excluding Pathologies) by The Assurance Maladie in France in 2017, by Type (in Million Euros)." Statista, Statista Inc., 30 Sep 2019, https://www.statista.com/statistics/756355/health-insurance-antidepressant-spending-france/
Cnamts, Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2017, by type (in million euros) Statista, https://www.statista.com/statistics/756355/health-insurance-antidepressant-spending-france/ (last visited December 21, 2024)
Antidepressant and mood-stabilizing treatment expenses (excluding pathologies) by the Assurance Maladie in France in 2017, by type (in million euros) [Graph], Cnamts, September 30, 2019. [Online]. Available: https://www.statista.com/statistics/756355/health-insurance-antidepressant-spending-france/
